Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Polymyxin B inactivation of lipopolysaccharide in vaccines of Gram-negative bacteria.

Literature DB >> 6266967

Polymyxin B inactivation of lipopolysaccharide in vaccines of Gram-negative bacteria.

Abstract

Endotoxin activity in suspensions of Bordetella pertussis, Escherichia coli, Haemophilus influenzae, and Pseudomonas aeruginosa was often markedly decreased by polymyxin B. Polymyxin B treatment may be a means to reduce inflammatory reactivity of lipopolysaccharide in vaccines of gram-negative bacteria.

Entities: Chemical Species

Mesh：

Substances：

Year: 1981 PMID： 6266967 PMCID： PMC350693 DOI： 10.1128/iai.33.1.315-318.1981

Source DB: PubMed Journal: Infect Immun ISSN： 0019-9567 Impact factor: 3.441

31 in total

1. Neutralization of the hemodynamic effects of endotoxin by polymyxin B.

Authors: J D Palmer; D Rifkind
Journal: Surg Gynecol Obstet Date: 1974-05

2. Endotoxin-induced intravascular coagulation: prevention with polymyxin B sulfate.

Authors: J J Corrigan; B M Bell
Journal: J Lab Clin Med Date: 1971-05

3. Prevention by polymyxin B of endotoxin lethality in mice.

Authors: D Rifkind
Journal: J Bacteriol Date: 1967-04 Impact factor: 3.490

4. Comparison of the pyrogenicity, Limulus activity mitogenicity and complement reactivity of several bacterial endotoxins and related compounds.

Authors: R J Elin; A L Sandberg; D L Rosentreich
Journal: J Immunol Date: 1976-10 Impact factor: 5.422

5. Inactivation of endotoxin by polymyxin B.

Authors: M S Cooperstock
Journal: Antimicrob Agents Chemother Date: 1974-10 Impact factor: 5.191

6. Polymyxin B sulfate modification of bacterial endotoxin: effects on the development of endotoxin shock in dogs.

Authors: A H From; J S Fong; R A Good
Journal: Infect Immun Date: 1979-03 Impact factor: 3.441

7. Neutralization of endotoxin toxicity in chick embryos by antibiotics.

Authors: D Rifkind; J D Palmer
Journal: J Bacteriol Date: 1966-10 Impact factor: 3.490

8. Adverse reactions and endotoxin content of polysaccharide vaccines.

Authors: T Kuronen; H Peltola; T Nors; N Haque; P H Mäkelä
Journal: Dev Biol Stand Date: 1977

9. Dissociation between mitogenicity and immunogenicity of TNP-lipopolysaccharide, a T-independent antigen.

Authors: M D Jacobs; D C Morrison
Journal: J Exp Med Date: 1975-06-01 Impact factor: 14.307

10. Association between mitogenicity and immunogenicity of 4-hydroxy-3,5-dinitrophenacetyl-lipopolysaccharide, a T-independent antigen.

Authors: E Smith; L Hammarström; A Coutinho
Journal: J Exp Med Date: 1976-06-01 Impact factor: 14.307

7 in total

1. Binding and neutralization of bacterial lipopolysaccharide by colistin nonapeptide.

Authors: H S Warren; S A Kania; G R Siber
Journal: Antimicrob Agents Chemother Date: 1985-07 Impact factor: 5.191

Review 2. Pertussis: the disease and new diagnostic methods.

Authors: R L Friedman
Journal: Clin Microbiol Rev Date: 1988-10 Impact factor: 26.132

3. Myelopoiesis in experimentally contaminated specific-pathogen-free and germfree mice during oral administration of polymyxin.

Authors: H Goris; F de Boer; D van der Waaij
Journal: Infect Immun Date: 1985-11 Impact factor: 3.441

4. Monokine production following in vitro stimulation of the THP-1 human monocytic cell line with pertussis vaccine components.

Authors: J Blood-Siegfried; E Crabb Breen; S Takeshita; O Martinez-Maza; D Vredevoe
Journal: J Clin Immunol Date: 1998-01 Impact factor: 8.317